NCT00291122View on ClinicalTrials.gov

An Examination of Predictors of Indicators of Response to Celecoxib in Women Who Have a Diagnosis of Early Breast Cancer

CompletedOBSERVATIONAL

Enrollment

100

Participants

Timeline

Start Date

January 31, 2003

Study Completion Date

December 31, 2005

Conditions

Breast Cancer

Interventions

DRUG

celecoxib 400 mg BID

Trial Locations (1)

66160

University of Kansas Medical Center, Kansas City

All Listed Sponsors

lead

University of Kansas

OTHER

NCT00291122 - An Examination of Predictors of Indicators of Response to Celecoxib in Women Who Have a Diagnosis of Early Breast Cancer | Biotech Hunter | Biotech Hunter